The company has five drugs on the market and several clinical programs across various therapeutic areas. Alnylam was founded in 2002 based on a Nobel Prize-winning breakthrough in biology, and it has a robust pipeline of investigational medicines in late-stage and early-stage clinical development. The company is a global and diverse employer that fosters a fun, inclusive, and dynamic work environment, and it has been recognized as a top employer by Science Magazine, Boston Globe, and Fast Company.